http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-6270224-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
filingDate | 2010-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_159cdc9b1d72c01fc9c8a4cbea92e301 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d401a4e0f9270d24a62c3bf650013b6 |
publicationDate | 2011-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CO-6270224-A2 |
titleOfInvention | DERIVATIVES 1,2,4- TRIAZOL AMINO AS MODULATORS OF MGLUR5 |
abstract | The present invention is directed to new compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the new compounds. 1.- A compound of Formula (I) where X is R1 is methyl, halogen or cyano; R2 is hydrogen or fluoro; R3 is C1-C3 alkyl or cyclopropyl; R4 is C1-C3 alkyl or cyclopropyl; R5 is hydrogen, C1-C3 alkyl or cyclopropyl; Z where R6 is hydrogen, fluoro, C1-C3 C1-C3 alkyl alkoxy; R7 is hydrogen, fluoro, C1-C3 alkyl or C1-C3 alkoxy; as well as pharmaceutically acceptable salts, hydrates, isoforms, tautomers and / or enantiomers thereof. |
priorityDate | 2008-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.